scPharmaceuticals
(NASDAQ) SCPH
scPharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$49.97M
Net Income (TTM)
$91.72M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SCPH News
SCPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout scPharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
164
CEO
John H. Tucker, MBA
Website
www.scpharmaceuticals.comHeadquarters
Burlington, MA 01803, US
SCPH Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
-21%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$24.97M
Operating Income
$64.78M
EBITDA
$77.43M
Operating Cash Flow
$70.54M
Capital Expenditure
$21.00K
Free Cash Flow
$70.56M
Cash & ST Invst.
$75.66M
Total Debt
$52.69M
scPharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.04M
+99.2%
Gross Profit
$11.03M
+91.7%
Gross Margin
68.76%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
162
N/A
Net Income
$18.02M
-5.5%
EBITDA
$16.56M
-11.1%
Quarterly Fundamentals
Net Cash
$11.64M
-307.0%
Accounts Receivable
$19.41M
+217.3%
Inventory
$14.57M
-4.8%
Long Term Debt
$53.17M
+29.1%
Short Term Debt
$264.00K
-30.5%
Return on Assets
-1.14%
N/A
Return on Invested Capital
-1.11%
N/A
Free Cash Flow
$16.11M
+20.3%
Operating Cash Flow
$16.11M
+20.3%